Malignant Hepatobiliary NeoplasmCancerGut health
What this study is
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
What's being tested
- Non-Interventional Study
Intervention · OTHER
Non-interventional study
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Malignant Hepatobiliary Neoplasm
- Enrolling
- 400 people
- Starts
- 2023-07-17
- Est. completion
- 2028-07-17
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients 18+ year of age with hepatobiliary cancers
You can't join if
- Patients under 18 years of age
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic in Rochester
Rochester, Minnesota, United States
- Clinical Trials Referral Office · Contact855-776-0015mayocliniccancerstudies@mayo.edu
- Nguyen H. Tran, M.D. · Principal investigator
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 22-012368
Principal investigator
Nguyen H. Tran, M.D.
Mayo Clinic in Rochester
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.